Lv41
460 积分 2025-07-09 加入
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis
12分钟前
待确认
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1小时前
已完结
Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease
1小时前
已完结
B-cell depletion in autoimmune diseases
1小时前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1小时前
已完结
POS0046 PRELIMINARY RESULTS OF AN OPEN-LABEL, MULTICENTRE, PHASE 1/2 STUDY TO ASSESS SAFETY, EFFICACY AND CELLULAR KINETICS OF YTB323 (RAPCABTAGENE AUTOLEUCEL), A RAPIDLY MANUFACTURED CAR T-CELL THERAPY TARGETING CD19 ON B CELLS, FOR SEVERE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
1个月前
已关闭
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production
1个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1个月前
已完结
Treatment of SLE with anti-CD19 CAR-T cells
1个月前
已完结
皖公网安备34019202002308
